ArticlePloS one2021

New monoclonal antibodies that recognize an unglycosylated, conserved, extracellular region of CD44 in vitro and in vivo, and can block tumorigenesis.

Daniel F Lusche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.